{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:45:20Z","timestamp":1792788320354,"version":"4.5.0"},"reference-count":125,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Calcium disorders clinic"},{"DOI":"10.13039\/100009776","name":"McMaster University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009776","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>An international working group (IWG) consisting of experts in X-linked hypophosphatemia (XLH) developed global guidelines providing a comprehensive, evidence-based approach to XLH diagnosis, management, and monitoring.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The IWG, consisting of 43 members as well as methodologists and a patient partner, conducted 2 systematic reviews (SRs) and narrative reviews to address key areas. The SRs addressed the impact of burosumab compared to conventional therapy (phosphate and active vitamin D) or no therapy on patient-important outcomes in adults. They also evaluated conventional therapy compared to no therapy. GRADE methodology was applied to evaluate the certainty of evidence. Non-GRADED recommendations were made in the presence of insufficient evidence to conduct SRs. These guidelines have been reviewed and endorsed by several medical and patient societies and organizations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The diagnosis of XLH is based on integrating clinical evaluation, laboratory findings confirming renal phosphate wasting (following exclusion of conditions mimicking XLH), and skeletal imaging. Fibroblast growth factor 23 measurement and DNA analysis are of value in the diagnosis, if available. Pathogenic or likely pathogenic variants in the PHEX gene are confirmatory but not necessary for the diagnosis. Management requires a multidisciplinary team knowledgeable and experienced in XLH. Effective medical therapy with burosumab can improve fracture and pseudofracture healing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Conclusion<\/jats:title>\n                    <jats:p>In adults with XLH and fractures or pseudofractures, burosumab is recommended over no therapy (strong recommendation, GRADEd). Additionally, burosumab is suggested as the preferred treatment compared to conventional therapy (conditional recommendation, GRADEd) in the absence of fractures or pseudofractures. If burosumab is not available, symptomatic adults should be treated with conventional therapy (Non-GRADEd recommendation).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf170","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T07:45:13Z","timestamp":1744271113000},"page":"2353-2370","source":"Crossref","is-referenced-by-count":29,"title":["X-Linked Hypophosphatemia Management in Adults: An International Working Group Clinical Practice Guideline"],"prefix":"10.1210","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3733-8956","authenticated-orcid":false,"given":"Aliya A","family":"Khan","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, McMaster University , Hamilton, ON L8S 4L8 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5378-5548","authenticated-orcid":false,"given":"Dalal S","family":"Ali","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, McMaster University , Hamilton, ON L8S 4L8 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5035-127X","authenticated-orcid":false,"given":"Natasha M","family":"Appelman-Dijkstra","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Center for Bone Quality, Leiden University Medical Center , Leiden 2300 ZA ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1328-6768","authenticated-orcid":false,"given":"Thomas O","family":"Carpenter","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics (Endocrinology), and Orthopaedics and Rehabilitation, Yale University School of Medicine , New Haven, CT 06520 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3463-3936","authenticated-orcid":false,"given":"Catherine","family":"Chaussain","sequence":"additional","affiliation":[{"name":"Department of Oral Medicine, Faculty of Dentistry, UMR 1333, Universit\u00e9 Paris Cit\u00e9 , Paris 75006 ,","place":["France"]},{"name":"Institut Imagine, INSERM 1163 , 75015 Paris ,","place":["France"]},{"name":"Department of Oral Medicine, APHP , Paris 75006 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7284-3467","authenticated-orcid":false,"given":"Erik A","family":"Imel","sequence":"additional","affiliation":[{"name":"Department of Medicine and Pediatrics, Endocrinology, Indiana University School of Medicine , Indianapolis, IN 46202 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9386-7732","authenticated-orcid":false,"given":"Suzanne M","family":"Jan de Beur","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Virginia School of Medicine , Charlottesville, VA 22903 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5936-3146","authenticated-orcid":false,"given":"Pablo","family":"Florenzano","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, School of Medicine Pontificia Universidad Cat\u00f3lica de Chile , Santiago 8320165, Regi\u00f3n Metropolitana ,","place":["Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7830-3237","authenticated-orcid":false,"given":"Hajar","family":"Abu Alrob","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact at McMaster University , Hamilton, ON L8S 4L8 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Aldabagh","sequence":"additional","affiliation":[{"name":"Faculty of Dentistry, University of Toronto , Toronto, ON M5G 2L3 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7396-7894","authenticated-orcid":false,"given":"R Todd","family":"Alexander","sequence":"additional","affiliation":[{"name":"Faculty of Medicine & Dentistry, The University of Alberta , Edmonton, AB T6G 2R3 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9426-9702","authenticated-orcid":false,"given":"Farah","family":"Alsarraf","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, McMaster University , Hamilton, ON L8S 4L8 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7561-9217","authenticated-orcid":false,"given":"Signe Sparre","family":"Beck-Nielsen","sequence":"additional","affiliation":[{"name":"Centre for Rare Diseases, Aarhus University Hospital , Aarhus N 8200 ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Aarhus University , Aarhus N 8200 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9417-3970","authenticated-orcid":false,"given":"Martin","family":"Biosse-Duplan","sequence":"additional","affiliation":[{"name":"Department of Oral Medicine, Faculty of Dentistry, UMR 1333, Universit\u00e9 Paris Cit\u00e9 , Paris 75006 ,","place":["France"]},{"name":"Institut Imagine, INSERM 1163 , 75015 Paris ,","place":["France"]},{"name":"Department of Oral Medicine, APHP , Paris 75006 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8582-8258","authenticated-orcid":false,"given":"Martine","family":"Cohen-Solal","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and reference center for Rare Bone Diseases, hopital Lariboisiere , Paris 75006 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1472-4117","authenticated-orcid":false,"given":"Rachel K","family":"Crowley","sequence":"additional","affiliation":[{"name":"Rare Disease Clinical Trial Network, University College Dublin , Dublin 4, D04 T6F4 ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1759-8419","authenticated-orcid":false,"given":"Karel","family":"Dandurand","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, Endocrinology Division, Universit\u00e9 de Sherbrooke , Sherbrooke, QC J1H 5N4 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1891-6765","authenticated-orcid":false,"given":"Guido","family":"Filler","sequence":"additional","affiliation":[{"name":"London Health Sciences Centre, Children's Hospital of Western Ontario , London, ON N6A 3K7 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3056-3624","authenticated-orcid":false,"given":"Lisa","family":"Friedlander","sequence":"additional","affiliation":[{"name":"Department of Oral Medicine, Faculty of Dentistry, UMR 1333, Universit\u00e9 Paris Cit\u00e9 , Paris 75006 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3610-3469","authenticated-orcid":false,"given":"Seiji","family":"Fukumoto","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tamaki-Aozora Hospital , Tokushima 779-3125 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9623-962X","authenticated-orcid":false,"given":"Claudia","family":"Gagnon","sequence":"additional","affiliation":[{"name":"Endocrinology and Nephrology Axis, CHU de Qu\u00e9bec-Universit\u00e9 Laval Research Centre , Qu\u00e9bec, QC G1V 4G2 ,","place":["Canada"]},{"name":"Department of Medicine, Universit\u00e9 Laval , Qu\u00e9bec, QC G1V 0A6 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3442-1407","authenticated-orcid":false,"given":"Paul","family":"Goodyer","sequence":"additional","affiliation":[{"name":"Research Institute of the McGill University Health Centre , Montreal, QC H3H 2L9 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1793-4603","authenticated-orcid":false,"given":"Corinna","family":"Grasemann","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Rare Diseases, Katholisches Klinikum Bochum and Ruhr-University Bochum , 44791 Bochum ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9302-7741","authenticated-orcid":false,"given":"Chelsey","family":"Grimbly","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Alberta , Edmonton, AB T6G 2R3 ,","place":["Canada"]},{"name":"Women and Children's Health Research Institute , Edmonton, AB T6G 1C9 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7284-4822","authenticated-orcid":false,"given":"Salma","family":"Hussein","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, McMaster University , Hamilton, ON L8S 4L8 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7985-0048","authenticated-orcid":false,"given":"Muhammad K","family":"Javaid","sequence":"additional","affiliation":[{"name":"Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford , Oxford OX3 7HE ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3604-303X","authenticated-orcid":false,"given":"Sarah","family":"Khan","sequence":"additional","affiliation":[{"name":"Trillium Health Partners, University of Toronto , Toronto, ON L5M 2N1 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8131-7947","authenticated-orcid":false,"given":"Aneal","family":"Khan","sequence":"additional","affiliation":[{"name":"M.A.G.I.C. Clinic (Metabolics and Genetics in Canada) , Calgary, AB T2E 7Z4 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0636-123X","authenticated-orcid":false,"given":"Anna","family":"Lehman","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University of British Columbia , Vancouver, BC V6T 1Z4 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6885-3953","authenticated-orcid":false,"given":"Willem F","family":"Lems","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Amsterdam UMC , Amsterdam 1105 AZ ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2026-9587","authenticated-orcid":false,"given":"E Michael","family":"Lewiecki","sequence":"additional","affiliation":[{"name":"New Mexico Clinical Research & Osteoporosis Center , Albuquerque, NM 87106 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9414-5873","authenticated-orcid":false,"given":"Ciara","family":"McDonnell","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology & Diabetes, Children's Health Ireland , Dublin D12 N512 ,","place":["Ireland"]},{"name":"Department of Paediatrics, School of Medicine, University of Dublin, Trinity College , Dublin D02 PN40 ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0576-4208","authenticated-orcid":false,"given":"Reza D","family":"Mirza","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact at McMaster University , Hamilton, ON L8S 4L8 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9271-0379","authenticated-orcid":false,"given":"Emmett","family":"Morgante","sequence":"additional","affiliation":[{"name":"Department of Kinesiology, University of Waterloo , Waterloo, ON N2L 3G1 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archibald","family":"Morrison","sequence":"additional","affiliation":[{"name":"Citadel Oral and Facial Surgery , Halifax, NS B3L 4H7 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2054-6898","authenticated-orcid":false,"given":"Anthony A","family":"Portale","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California San Francisco , San Francisco, CA 94115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4227-5638","authenticated-orcid":false,"given":"Yumie","family":"Rhee","sequence":"additional","affiliation":[{"name":"Endocrine Research Institute, Department of Internal Medicine, Yonsei University College of Medicine , Seoul 03722 ,","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8147-7315","authenticated-orcid":false,"given":"Eric T","family":"Rush","sequence":"additional","affiliation":[{"name":"Division of Clinical Genetics, Children's Mercy Kansas City , Kansas City, MO 64108 ,","place":["USA"]},{"name":"Department of Pediatrics, University of Missouri-Kansas City School of Medicine , Kansas City, MO 64108-2792 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8366-8625","authenticated-orcid":false,"given":"Heide","family":"Siggelkow","sequence":"additional","affiliation":[{"name":"Department of Trauma, Orthopedics and Reconstructive Surgery, University Medical Center Goettingen , 37075 Goettingen ,","place":["Germany"]},{"name":"MVZ Endokrinologikum Goettingen , 37075 Goettingen ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0157-1855","authenticated-orcid":false,"given":"Sotirios","family":"Tetradis","sequence":"additional","affiliation":[{"name":"Division of Diagnostic and Surgical Sciences, UCLA School of Dentistry , Los Angeles, CA 90095 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8827-9883","authenticated-orcid":false,"given":"Laura","family":"Tosi","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, George Washington University School of Medicine and Health Sciences , Washington, DC 20052 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1557-9185","authenticated-orcid":false,"given":"Leanne M","family":"Ward","sequence":"additional","affiliation":[{"name":"Children's Hospital of Eastern Ontario, Department of Pediatrics, University of Ottawa , Ottawa, ON K1H 8L1 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2352-5718","authenticated-orcid":false,"given":"Gordon","family":"Guyatt","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact at McMaster University , Hamilton, ON L8S 4L8 ,","place":["Canada"]},{"name":"Department of Medicine, McMaster University , Hamilton, ON L8S 4L8 ,","place":["Canada"]},{"name":"MAGIC Evidence Ecosystem Foundation [www.magicevidence.org] , Oslo 0456 ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8741-0592","authenticated-orcid":false,"given":"Maria Luisa","family":"Brandi","sequence":"additional","affiliation":[{"name":"Institute of Endocrine and Metabolic Sciences, Vita-Salute San Raffaele University and IRCCS , Milan 20132 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"issue":"5","key":"2025071507130619100_dgaf170-B1","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2005111185","article-title":"Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D","volume":"17","author":"Liu","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2025071507130619100_dgaf170-B2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/EJE-15-0661","article-title":"Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms","volume":"174","author":"Che","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2025071507130619100_dgaf170-B3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/0022034516677528","article-title":"Phosphate and vitamin D prevent periodontitis in X-linked hypophosphatemia","volume":"96","author":"Biosse Duplan","year":"2017","journal-title":"J Dent Res"},{"issue":"8","key":"2025071507130619100_dgaf170-B4","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/jbmr.3475","article-title":"A randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of burosumab, an anti-FGF23 antibody, in adults with X-linked hypophosphatemia: week 24 primary analysis","volume":"33","author":"Insogna","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"7650","key":"2025071507130619100_dgaf170-B5","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"2025071507130619100_dgaf170-B6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"2025071507130619100_dgaf170-B7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"2025071507130619100_dgaf170-B8","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","article-title":"GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"2025071507130619100_dgaf170-B9","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jclinepi.2013.02.003","article-title":"GRADE guidelines: 15. Going from evidence to recommendation\u2014determinants of a recommendation's direction and strength","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"2025071507130619100_dgaf170-B10","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00198-021-05997-1","article-title":"Burden of disease and clinical targets in adult patients with X-linked hypophosphatemia. A comprehensive review","volume":"32","author":"Giannini","year":"2021","journal-title":"Osteoporos Int"},{"issue":"7","key":"2025071507130619100_dgaf170-B11","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A clinician's guide to X-linked hypophosphatemia","volume":"26","author":"Carpenter","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2025071507130619100_dgaf170-B12","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EC-13-0103","article-title":"Therapeutic management of hypophosphatemic rickets from infancy to adulthood","volume":"3","author":"Linglart","year":"2014","journal-title":"Endocr Connect"},{"issue":"7","key":"2025071507130619100_dgaf170-B13","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/jbmr.3992","article-title":"Hyperparathyroidism in patients with X-linked hypophosphatemia","volume":"35","author":"Lecoq","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2025071507130619100_dgaf170-B14","first-page":"23","article-title":"Relation of plasma phosphate concentration to renal tubular reabsorption of phosphate","volume":"37","author":"Bijvoet","year":"1969","journal-title":"Clin Sci"},{"issue":"11","key":"2025071507130619100_dgaf170-B15","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1002\/jbmr.4702","article-title":"Determination of FGF23 levels for the diagnosis of FGF23-mediated hypophosphatemia","volume":"37","author":"Hartley","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2025071507130619100_dgaf170-B16","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1007\/s00467-022-05505-5","article-title":"Rickets guidance: part II-management","volume":"37","author":"Haffner","year":"2022","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"2025071507130619100_dgaf170-B17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/jhg.2016.119","article-title":"INPPL1 gene mutations in opsismodysplasia","volume":"62","author":"Fradet","year":"2017","journal-title":"J Hum Genet"},{"issue":"10","key":"2025071507130619100_dgaf170-B18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJM198503073121003","article-title":"Hereditary hypophosphatemic rickets with hypercalciuria","volume":"312","author":"Tieder","year":"1985","journal-title":"N Engl J Med"},{"issue":"2","key":"2025071507130619100_dgaf170-B19","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1681\/ASN.2014101025","article-title":"Autosomal-recessive mutations in SLC34A1 encoding sodium-phosphate cotransporter 2A cause idiopathic infantile hypercalcemia","volume":"27","author":"Schlingmann","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2025071507130619100_dgaf170-B20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1750-1172-5-28","article-title":"Dent's disease","volume":"5","author":"Devuyst","year":"2010","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"2025071507130619100_dgaf170-B21","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/jimd.12134","article-title":"Management of bone disease in cystinosis: statement from an international conference","volume":"42","author":"Hohenfellner","year":"2019","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"2025071507130619100_dgaf170-B22","doi-asserted-by":"crossref","first-page":"e34764","DOI":"10.1371\/journal.pone.0034764","article-title":"A new human NHERF1 mutation decreases renal phosphate transporter NPT2a expression by a PTH-independent mechanism","volume":"7","author":"Courbebaisse","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"2025071507130619100_dgaf170-B23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00223-010-9373-0","article-title":"Phenotype presentation of hypophosphatemic rickets in adults","volume":"87","author":"Beck-Nielsen","year":"2010","journal-title":"Calcif Tissue Int"},{"issue":"7","key":"2025071507130619100_dgaf170-B24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","article-title":"Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia","volume":"15","author":"Haffner","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"2025071507130619100_dgaf170-B25","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41574-022-00662-x","article-title":"Interdisciplinary management of FGF23-related phosphate wasting syndromes: a consensus statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia","volume":"18","author":"Trombetti","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"2025071507130619100_dgaf170-B26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"4","key":"2025071507130619100_dgaf170-B27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00439-009-0631-z","article-title":"PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets","volume":"125","author":"Gaucher","year":"2009","journal-title":"Hum Genet"},{"issue":"11","key":"2025071507130619100_dgaf170-B28","first-page":"4075","article-title":"X-linked hypophosphatemia: a search for gender, race, anticipation, or parent of origin effects on disease expression in children","volume":"81","author":"Whyte","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2025071507130619100_dgaf170-B29","doi-asserted-by":"crossref","first-page":"1215952","DOI":"10.3389\/fped.2023.1215952","article-title":"A genetic study of a Brazilian cohort of patients with X-linked hypophosphatemia reveals no correlation between genotype and phenotype","volume":"11","author":"Borghi","year":"2023","journal-title":"Front Pediatr"},{"issue":"7","key":"2025071507130619100_dgaf170-B30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/jhg.2012.56","article-title":"Mutational analysis of PHEX, FGF23, DMP1, SLC34A3 and CLCN5 in patients with hypophosphatemic rickets","volume":"57","author":"Beck-Nielsen","year":"2012","journal-title":"J Hum Genet"},{"key":"2025071507130619100_dgaf170-B31","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bonr.2017.09.002","article-title":"Tumor-induced osteomalacia","volume":"7","author":"Florenzano","year":"2017","journal-title":"Bone Rep"},{"issue":"4","key":"2025071507130619100_dgaf170-B32","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jbmr.4233","article-title":"Burosumab for the treatment of tumor-induced osteomalacia","volume":"36","author":"Jan de Beur","year":"2021","journal-title":"J Bone Miner Res"},{"key":"2025071507130619100_dgaf170-B33","first-page":"354314","article-title":"Successful medical therapy for hypophosphatemic rickets due to mitochondrial Complex I deficiency induced de toni-debr\u00e9-fanconi syndrome","volume":"2013","author":"Bowden","year":"2013","journal-title":"Case Rep Pediatr"},{"issue":"5","key":"2025071507130619100_dgaf170-B34","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.bone.2003.12.025","article-title":"Resolution of severe, adolescent-onset hypophosphatemic rickets following resection of an FGF-23-producing tumour of the distal ulna","volume":"34","author":"Ward","year":"2004","journal-title":"Bone"},{"issue":"12","key":"2025071507130619100_dgaf170-B35","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/jbmr.3843","article-title":"Burosumab improved histomorphometric measures of osteomalacia in adults with X-linked hypophosphatemia: a phase 3, single-arm, international trial","volume":"34","author":"Insogna","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2025071507130619100_dgaf170-B36","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s00198-017-3949-8","article-title":"Evaluation of bone mineral density and microarchitectural parameters by DXA and HR-pQCT in 37 children and adults with X-linked hypophosphatemic rickets","volume":"28","author":"Colares Neto","year":"2017","journal-title":"Osteoporos Int"},{"key":"2025071507130619100_dgaf170-B37","doi-asserted-by":"crossref","first-page":"117179","DOI":"10.1016\/j.bone.2024.117179","article-title":"Evaluation of bone density and microarchitecture in adult patients with X-linked hypophosphatemic rickets: a pilot longitudinal study","volume":"187","author":"Funck-Brentano","year":"2024","journal-title":"Bone"},{"issue":"1","key":"2025071507130619100_dgaf170-B38","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/jbmr.2310","article-title":"Bone geometry, volumetric density, microarchitecture, and estimated bone strength assessed by HR-pQCT in adult patients with hypophosphatemic rickets","volume":"30","author":"Shanbhogue","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2025071507130619100_dgaf170-B39","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1007\/s00198-013-2286-9","article-title":"High bone mineral apparent density in children with X-linked hypophosphatemia","volume":"24","author":"Beck-Nielsen","year":"2013","journal-title":"Osteoporos Int"},{"issue":"1","key":"2025071507130619100_dgaf170-B40","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s13023-023-02882-4","article-title":"The international X-linked hypophosphatemia (XLH) registry: first interim analysis of baseline demographic, genetic and clinical data","volume":"18","author":"Ariceta","year":"2023","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2025071507130619100_dgaf170-B41","doi-asserted-by":"crossref","first-page":"e488","DOI":"10.1210\/clinem\/dgad608","article-title":"Reassuring data on the cardiovascular risk in adults with X-linked hypophosphatemia receiving conventional therapy","volume":"109","author":"Bouzemane","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025071507130619100_dgaf170-B42","doi-asserted-by":"crossref","first-page":"e10437","DOI":"10.1002\/jbm4.10437","article-title":"Renal phosphate handling: independent effects of circulating FGF23, PTH, and calcium","volume":"5","author":"McKenna","year":"2021","journal-title":"JBMR Plus"},{"issue":"3","key":"2025071507130619100_dgaf170-B43","doi-asserted-by":"crossref","first-page":"e001714","DOI":"10.1136\/rmdopen-2021-001714","article-title":"Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension","volume":"7","author":"Briot","year":"2021","journal-title":"RMD Open"},{"issue":"2","key":"2025071507130619100_dgaf170-B44","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0031-3955(05)70485-5","article-title":"New perspectives on the biology and treatment of X-linked hypophosphatemic rickets","volume":"44","author":"Carpenter","year":"1997","journal-title":"Pediatr Clin North Am"},{"issue":"3","key":"2025071507130619100_dgaf170-B45","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00223-009-9270-6","article-title":"Survey of the enthesopathy of X-linked hypophosphatemia and its characterization in hyp mice","volume":"85","author":"Liang","year":"2009","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"2025071507130619100_dgaf170-B46","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00005792-198911000-00002","article-title":"X-linked hypophosphatemia: a clinical, biochemical, and histopathologic assessment of morbidity in adults","volume":"68","author":"Reid","year":"1989","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"2025071507130619100_dgaf170-B47","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1210\/js.2018-00365","article-title":"The lifelong impact of X-linked hypophosphatemia: results from a burden of disease survey","volume":"3","author":"Skrinar","year":"2019","journal-title":"J Endocr Soc"},{"issue":"3","key":"2025071507130619100_dgaf170-B48","doi-asserted-by":"crossref","first-page":"e1249","DOI":"10.1210\/clinem\/dgab739","article-title":"Musculoskeletal features in adults with X-linked hypophosphatemia: an analysis of clinical trial and survey data","volume":"107","author":"Javaid","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2025071507130619100_dgaf170-B49","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1210\/JC.2015-2199","article-title":"Conventional therapy in adults with X-linked hypophosphatemia: effects on enthesopathy and dental disease","volume":"100","author":"Connor","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025071507130619100_dgaf170-B50","doi-asserted-by":"crossref","first-page":"e1798","DOI":"10.1210\/clinem\/dgaa064","article-title":"Osteoarthritis, osteophytes, and enthesophytes affect biomechanical function in adults with X-linked hypophosphatemia","volume":"105","author":"Steele","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2025071507130619100_dgaf170-B51","doi-asserted-by":"crossref","first-page":"dgaa242","DOI":"10.1210\/clinem\/dgaa242","article-title":"Enthesopathy, osteoarthritis, and mobility in X-linked hypophosphatemia1","volume":"105","author":"Imel","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025071507130619100_dgaf170-B52","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00223-019-00568-3","article-title":"Continued beneficial effects of burosumab in adults with X-linked hypophosphatemia: results from a 24-week treatment continuation period after a 24-week double-blind placebo-controlled period","volume":"105","author":"Portale","year":"2019","journal-title":"Calcif Tissue Int"},{"issue":"7","key":"2025071507130619100_dgaf170-B53","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1210\/jc.2015-1551","article-title":"Prolonged correction of Serum phosphorus in adults with X-linked hypophosphatemia using monthly doses of KRN23","volume":"100","author":"Imel","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025071507130619100_dgaf170-B54","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1210\/js.2018-00338","article-title":"Nephrocalcinosis and nephrolithiasis in X-linked hypophosphatemic rickets: diagnostic imaging and risk factors","volume":"3","author":"Colares Neto","year":"2019","journal-title":"J Endocr Soc"},{"issue":"3","key":"2025071507130619100_dgaf170-B55","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1507\/endocrj.EJ16-0199","article-title":"Hypertension is a characteristic complication of X-linked hypophosphatemia","volume":"64","author":"Nakamura","year":"2017","journal-title":"Endocr J"},{"issue":"3","key":"2025071507130619100_dgaf170-B56","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00467-022-05636-9","article-title":"X-linked hypophosphatemia, obesity and arterial hypertension: data from the XLH21 study","volume":"38","author":"Bloudeau","year":"2023","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"2025071507130619100_dgaf170-B57","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s10545-018-0147-6","article-title":"Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations","volume":"41","author":"Chesher","year":"2018","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"2025071507130619100_dgaf170-B58","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13023-019-1014-8","article-title":"FGF23 and its role in X-linked hypophosphatemia-related morbidity","volume":"14","author":"Beck-Nielsen","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"2025071507130619100_dgaf170-B59","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00223-022-01010-x","article-title":"Bone deformities and kidney failure: coincidence of PHEX-related hypophosphatemic rickets and m.3243A &gt; G mitochondrial disease","volume":"111","author":"Nielsen","year":"2022","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"2025071507130619100_dgaf170-B60","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s40124-021-00249-6","article-title":"Animal, human, and 23Na MRI imaging evidence for the negative impact of high dietary salt in children","volume":"9","author":"Filler","year":"2021","journal-title":"Curr Pediatr Rep"},{"issue":"4","key":"2025071507130619100_dgaf170-B61","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/ki.1996.149","article-title":"Renal Na(+)-phosphate cotransporter gene expression in X-linked Hyp and Gy mice","volume":"49","author":"Tenenhouse","year":"1996","journal-title":"Kidney Int"},{"issue":"4","key":"2025071507130619100_dgaf170-B62","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1542\/peds.100.4.675","article-title":"The relationship between urinary calcium, sodium, and potassium excretion and the role of potassium in treating idiopathic hypercalciuria","volume":"100","author":"Osorio","year":"1997","journal-title":"Pediatrics"},{"issue":"3","key":"2025071507130619100_dgaf170-B63","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00467-018-4179-9","article-title":"Educational review: role of the pediatric nephrologists in the work-up and management of kidney stones","volume":"35","author":"Rodriguez Cuellar","year":"2020","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"2025071507130619100_dgaf170-B64","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00467-023-06185-5","article-title":"Limitations of U25 CKiD and CKD-EPI eGFR formulae in patients 2\u201320 years of age with measured GFR&gt;60 mL\/min\/1.73 m2\u2014a cross-sectional study","volume":"39","author":"Filler","year":"2024","journal-title":"Pediatric Nephrology"},{"issue":"3","key":"2025071507130619100_dgaf170-B65","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"2025071507130619100_dgaf170-B66","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00467-003-1271-5","article-title":"Should the schwartz formula for estimation of GFR be replaced by cystatin C formula?","volume":"18","author":"Filler","year":"2003","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"2025071507130619100_dgaf170-B67","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12882-018-0995-1","article-title":"Low agreement between modified-schwartz and CKD-EPI eGFR in young adults: a retrospective longitudinal cohort study","volume":"19","author":"Webster-Clark","year":"2018","journal-title":"BMC Nephrol"},{"issue":"3","key":"2025071507130619100_dgaf170-B68","doi-asserted-by":"crossref","first-page":"e1001979","DOI":"10.1371\/journal.pmed.1001979","article-title":"Comparison of the schwartz and CKD-EPI equations for estimating glomerular filtration rate in children, adolescents, and adults: a retrospective cross-sectional study","volume":"13","author":"Selistre","year":"2016","journal-title":"PLoS Med"},{"issue":"5","key":"2025071507130619100_dgaf170-B69","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/ndt\/gfv454","article-title":"An estimated glomerular filtration rate equation for the full age spectrum","volume":"31","author":"Pottel","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2025071507130619100_dgaf170-B70","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from Serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"issue":"4-5","key":"2025071507130619100_dgaf170-B71","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1159\/000513698","article-title":"The 2020 updated KDOQI clinical practice guidelines for nutrition in chronic kidney disease","volume":"50","author":"Ikizler","year":"2021","journal-title":"Blood Purif"},{"issue":"3","key":"2025071507130619100_dgaf170-B72","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1053\/j.ajkd.2021.09.013","article-title":"KDOQI US commentary on the 2021 KDIGO clinical practice guideline for the management of blood pressure in CKD","volume":"79","author":"Drawz","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"2025071507130619100_dgaf170-B73","doi-asserted-by":"crossref","first-page":"e20171904","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"issue":"3","key":"2025071507130619100_dgaf170-B74","doi-asserted-by":"crossref","first-page":"e20182096","DOI":"10.1542\/peds.2018-2096","article-title":"Diagnosis, evaluation, and management of high blood pressure in children and adolescents","volume":"142","author":"Baker-Smith","year":"2018","journal-title":"Pediatrics"},{"issue":"8","key":"2025071507130619100_dgaf170-B75","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1007\/s00467-022-05856-z","article-title":"Impact of the 2022 American Heart Association pediatric ambulatory blood pressure monitoring statement on the diagnosis of hypertension","volume":"38","author":"Sharma","year":"2023","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"2025071507130619100_dgaf170-B76","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/jbmr\/zjae127","article-title":"Nephrocalcinosis and kidney function in children and adults with X-linked hypophosphatemia: baseline results from a large longitudinal study","volume":"39","author":"Portale","year":"2024","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2025071507130619100_dgaf170-B77","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0009-9260(88)80224-1","article-title":"The petrous temporal bone and deafness in X-linked hypophosphataemic osteomalacia","volume":"39","author":"O'Malley","year":"1988","journal-title":"Clin Radiol"},{"issue":"1","key":"2025071507130619100_dgaf170-B78","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00198-020-05548-0","article-title":"Burden of disease associated with X-linked hypophosphataemia in adults: a systematic literature review","volume":"32","author":"Seefried","year":"2021","journal-title":"Osteoporos Int"},{"issue":"1","key":"2025071507130619100_dgaf170-B79","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13023-016-0538-4","article-title":"Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia","volume":"11","author":"Forestier-Zhang","year":"2016","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"2025071507130619100_dgaf170-B80","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s11136-020-02465-x","article-title":"Exploring the burden of X-linked hypophosphatemia: a European multi-country qualitative study","volume":"29","author":"Lo","year":"2020","journal-title":"Qual Life Res"},{"issue":"4","key":"2025071507130619100_dgaf170-B81","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1507\/endocrj.EJ21-0386","article-title":"Burden of disease of X-linked hypophosphatemia in Japanese and Korean patients: a cross-sectional survey","volume":"69","author":"Ito","year":"2022","journal-title":"Endocr J"},{"issue":"1","key":"2025071507130619100_dgaf170-B82","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s13023-022-02452-0","article-title":"Health-related quality of life of X-linked hypophosphatemia in Spain","volume":"17","author":"Yanes","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"2025071507130619100_dgaf170-B83","doi-asserted-by":"publisher","first-page":"dgaf104","DOI":"10.1210\/clinem\/dgaf104","article-title":"Pain, quality of life, and mental health in adults with X-linked hypophosphatemia: a cross-sectional study","author":"Diaz-delCastillo","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025071507130619100_dgaf170-B84","first-page":"879","article-title":"A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets","volume":"75","author":"Sullivan","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2025071507130619100_dgaf170-B85","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.3390\/jcm12082906","article-title":"Different efficacy of burosumab on physical performance and Serum phosphate in adult patients with X-linked hyphophosphatemic rickets during the first six-month of treatment","volume":"12","author":"Arcidiacono","year":"2023","journal-title":"J Clin Med"},{"key":"2025071507130619100_dgaf170-B86","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.bonr.2016.05.004","article-title":"Effect of four monthly doses of a human monoclonal anti-FGF23 antibody (KRN23) on quality of life in X-linked hypophosphatemia","volume":"5","author":"Ruppe","year":"2016","journal-title":"Bone Rep"},{"issue":"2","key":"2025071507130619100_dgaf170-B87","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ejendo\/lvae089","article-title":"Metabolically healthy obesity in adults with X-linked hypophosphatemia","volume":"191","author":"Lecoq","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"2025071507130619100_dgaf170-B88","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bone.2019.06.025","article-title":"Hyperparathyroidism and parathyroidectomy in X-linked hypophosphatemia patients","volume":"127","author":"DeLacey","year":"2019","journal-title":"Bone"},{"issue":"3","key":"2025071507130619100_dgaf170-B89","doi-asserted-by":"crossref","first-page":"274","DOI":"10.14310\/horm.2002.1277","article-title":"Cinacalcet in hyperparathyroidism secondary to X-linked hypophosphatemic rickets: case report and brief literature review","volume":"9","author":"Yavropoulou","year":"2010","journal-title":"Hormones (Athens)"},{"issue":"3","key":"2025071507130619100_dgaf170-B90","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2215\/CJN.04981107","article-title":"Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets","volume":"3","author":"Alon","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"suppl_1","key":"2025071507130619100_dgaf170-B91","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1530\/EJE-08-0383","article-title":"A case of X-linked hypophosphatemic rickets: complications and the therapeutic use of cinacalcet","volume":"159","author":"Raeder","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2025071507130619100_dgaf170-B92","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00223-022-01006-7","article-title":"Efficacy of burosumab in adults with X-linked hypophosphatemia (XLH): a post hoc subgroup analysis of a randomized double-blind placebo-controlled phase 3 study","volume":"111","author":"Brandi","year":"2022","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"2025071507130619100_dgaf170-B93","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1210\/clinem\/dgac518","article-title":"Long-term burosumab administration is safe and effective in adults with X-linked hypophosphatemia","volume":"108","author":"Weber","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025071507130619100_dgaf170-B94","doi-asserted-by":"crossref","first-page":"e002676","DOI":"10.1136\/rmdopen-2022-002676","article-title":"Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment","volume":"9","author":"Kamenicky","year":"2023","journal-title":"RMD Open"},{"issue":"(6)","key":"2025071507130619100_dgaf170-B95","first-page":"1767","article-title":"Systematic review: efficacy of medical therapy on outcomes important to adult patients with X-linked hypophosphatemia","volume":"110","author":"Ali","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025071507130619100_dgaf170-B96","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1148\/36.6.651","article-title":"Pseudofractures in diseases affecting the skeletal system","volume":"36","author":"Camp","year":"1941","journal-title":"Radiology"},{"issue":"2","key":"2025071507130619100_dgaf170-B97","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5001\/omj.2010.38","article-title":"Looser's zone","volume":"25","author":"Ahmad","year":"2010","journal-title":"Oman Med J"},{"issue":"13","key":"2025071507130619100_dgaf170-B98","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/jama.1964.03060260029006","article-title":"Fatigue, insufficiency, and pathologic fractures","volume":"187","author":"Pentecost","year":"1964","journal-title":"JAMA"},{"issue":"8","key":"2025071507130619100_dgaf170-B99","doi-asserted-by":"crossref","first-page":"bvac086","DOI":"10.1210\/jendso\/bvac086","article-title":"Whole body, whole life, whole family: patients\u2019 perspectives on X-linked hypophosphatemia","volume":"6","author":"Hamilton","year":"2022","journal-title":"J Endocr Soc"},{"issue":"2","key":"2025071507130619100_dgaf170-B100","doi-asserted-by":"crossref","first-page":"176","DOI":"10.17294\/2330-0698.1727","article-title":"Giving credence to the experience of X-linked hypophosphatemia in adulthood: an interprofessional mixed-methods study","volume":"7","author":"Hughes","year":"2020","journal-title":"J Patient Cent Res Rev"},{"key":"2025071507130619100_dgaf170-B101","volume-title":"X-Linked Hypophosphatemia","author":"Laurent","year":"1993"},{"issue":"2","key":"2025071507130619100_dgaf170-B102","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1152\/physrev.00027.2015","article-title":"Maternal mineral and bone metabolism during pregnancy, lactation, and post-weaning recovery","volume":"96","author":"Kovacs","year":"2016","journal-title":"Physiol Rev"},{"issue":"1","key":"2025071507130619100_dgaf170-B103","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/0002-9378(62)90278-8","article-title":"Calcium and phosphorus dynamics in pregnancy","volume":"83","author":"Kerr","year":"1962","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2025071507130619100_dgaf170-B104","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1471-0528.1998.tb10052.x","article-title":"Renal reabsorption of inorganic phosphorus in pregnancy in relation to the calciotropic hormones","volume":"105","author":"Weiss","year":"1998","journal-title":"BJOG"},{"issue":"5","key":"2025071507130619100_dgaf170-B105","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000506477","article-title":"Fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein levels in healthy children and, pregnant and puerperal women","volume":"92","author":"Ozsen","year":"2020","journal-title":"Horm Res Paediatr"},{"issue":"2","key":"2025071507130619100_dgaf170-B106","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1530\/EJE-18-0541","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: hypoparathyroidism in pregnancy: review and evidence-based recommendations for management","volume":"180","author":"Khan","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2025071507130619100_dgaf170-B107","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/jbmr.2186","article-title":"Elevated fibroblast growth factor 23 exerts its effects on placenta and regulates vitamin D metabolism in pregnancy of hyp mice","volume":"29","author":"Ohata","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2025071507130619100_dgaf170-B108","doi-asserted-by":"crossref","first-page":"bqaa202","DOI":"10.1210\/endocr\/bqaa202","article-title":"Murine fetal Serum phosphorus is set independent of FGF23 and PTH, except in the presence of maternal phosphate loading","volume":"162","author":"Sellars","year":"2021","journal-title":"Endocrinology"},{"issue":"5","key":"2025071507130619100_dgaf170-B109","doi-asserted-by":"crossref","first-page":"794","DOI":"10.12891\/ceog4385.2018","article-title":"Pregnancy in patient with X-linked hypophosphatemic rickets\u2014management and outcome","volume":"45","author":"Dobrowolska-Redo","year":"2018","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"5","key":"2025071507130619100_dgaf170-B110","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1601-0825.2006.01326.x","article-title":"Dentin structure in familial hypophosphatemic rickets: benefits of vitamin D and phosphate treatment","volume":"13","author":"Chaussain-Miller","year":"2007","journal-title":"Oral Dis"},{"issue":"1","key":"2025071507130619100_dgaf170-B111","doi-asserted-by":"crossref","first-page":"e210564","DOI":"10.1530\/EC-21-0564","article-title":"Oral health-related quality of life in patients with X-linked hypophosphatemia: a qualitative exploration","volume":"11","author":"Nguyen","year":"2022","journal-title":"Endocr Connect"},{"issue":"1","key":"2025071507130619100_dgaf170-B112","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1210\/clinem\/dgab580","article-title":"Prevalence of enthesopathies in adults with X-linked hypophosphatemia: analysis of risk factors","volume":"107","author":"Herrou","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025071507130619100_dgaf170-B113","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/joor.13114","article-title":"Oral health-related quality of life in X-linked hypophosphataemia and osteogenesis imperfecta","volume":"48","author":"Gj\u00f8rup","year":"2021","journal-title":"J Oral Rehabil"},{"issue":"3","key":"2025071507130619100_dgaf170-B114","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1067\/mpd.2003.119","article-title":"Dental abnormalities in patients with familial hypophosphatemic vitamin D-resistant rickets: prevention by early treatment with 1-hydroxyvitamin D","volume":"142","author":"Chaussain-Miller","year":"2003","journal-title":"J Pediatr"},{"issue":"4","key":"2025071507130619100_dgaf170-B115","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.bone.2012.01.010","article-title":"Tooth dentin defects reflect genetic disorders affecting bone mineralization","volume":"50","author":"Opsahl Vital","year":"2012","journal-title":"Bone"},{"key":"2025071507130619100_dgaf170-B116","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bone.2017.07.026","article-title":"Tissue-specific mineralization defects in the periodontium of the Hyp mouse model of X-linked hypophosphatemia","volume":"103","author":"Coyac","year":"2017","journal-title":"Bone"},{"issue":"4","key":"2025071507130619100_dgaf170-B117","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/0022034520901719","article-title":"Dentoalveolar defects in the hyp mouse model of X-linked hypophosphatemia","volume":"99","author":"Zhang","year":"2020","journal-title":"J Dent Res"},{"issue":"11","key":"2025071507130619100_dgaf170-B118","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1902\/jop.2011.100736","article-title":"Periodontal status of patients with hypophosphatemic rickets: a case series","volume":"82","author":"Ye","year":"2011","journal-title":"J Periodontol"},{"issue":"4","key":"2025071507130619100_dgaf170-B119","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1563\/1548-1336(1998)024<0214:IPAGTR>2.3.CO;2","article-title":"Implant placement and guided tissue regeneration in a patient with congenital vitamin D-resistant rickets","volume":"24","author":"Resnick","year":"1998","journal-title":"J Oral Implantol"},{"issue":"1","key":"2025071507130619100_dgaf170-B120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40729-019-0169-3","article-title":"Prosthetic rehabilitation of a patient with X-linked hypophosphatemia using dental implants: a case report and review of the literature","volume":"5","author":"James","year":"2019","journal-title":"Int J Implant Dent"},{"issue":"2","key":"2025071507130619100_dgaf170-B121","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/14653125211039521","article-title":"X-linked hypophosphatemic rickets: orthodontic considerations and management. A case report","volume":"49","author":"Gibson","year":"2022","journal-title":"J Orthod"},{"issue":"6","key":"2025071507130619100_dgaf170-B122","first-page":"395","article-title":"Orthodontic treatment of a patient with hypophosphatemic vitamin D-resistant rickets","volume":"64","author":"Kawakami","year":"1997","journal-title":"ASDC J Dent Child"},{"issue":"3","key":"2025071507130619100_dgaf170-B123","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ortho.2020.06.003","article-title":"Orthodontic treatment of a nine-year-old patient with hypophosphatemic rickets diagnosed since the age of two: a case report","volume":"18","author":"Makrygiannakis","year":"2020","journal-title":"Int Orthod"},{"issue":"7","key":"2025071507130619100_dgaf170-B124","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2842.2009.01963.x","article-title":"Craniofacial morphology in patients with hypophosphataemic vitamin-D-resistant rickets: a cephalometric study","volume":"36","author":"Al-Jundi","year":"2009","journal-title":"J Oral Rehabil"},{"issue":"6","key":"2025071507130619100_dgaf170-B125","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1210\/clinem\/dgac732","article-title":"Effect of conventional treatment on dental complications and ectopic ossifications among 30 adults with XLH","volume":"108","author":"Kato","year":"2023","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf170\/62946857\/dgaf170.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/8\/2353\/62946857\/dgaf170.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/8\/2353\/62946857\/dgaf170.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T11:13:55Z","timestamp":1752578035000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/8\/2353\/8115450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":125,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,4,17]]},"published-print":{"date-parts":[[2025,7,15]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf170","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,4,17]]}}}